Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Study Identifier
190342-022
CT.gov Identifier
NCT00168363
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Other
  • Ocular Hypertension
    • Study Drug
  • brimonidine
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * ocular hypertension or glaucoma in both eyes * currently treated with brimonidine * requires IOP-lowering therapy in both eyes
    Exclusion Criteria:
    * uncontrolled systemic disease * known allergy or sensitivity to brimonidine

    Protocol Summary

    This Study will evaluate the safety and efficacy of brimonidine in patients with glaucoma or ocular hypertension

    Study Locations

    No locations found.